Non-Drug-Eluting Device Market is Forecasted to Reach USD 10.4 Billion in 2030, Says Stratview Research

The global Non-Drug-Eluting Device Market is projected to witness a growth rate of 6.7% annually from 2024 to 2030, with an anticipated size of USD 10.4 billion in 2030, according to an analysis by Stratview Research.

Stratview Research, a global market research firm has launched a report on the global Non-Drug-Eluting Device Market which provides a comprehensive outlook of the global and regional market, industry forecast, current & emerging trends, segment analysis, competitive landscape, & more.

Click here to get a free sample of the report: https://www.stratviewresearch.com/Request-Sample/3849/non-drug-eluting-device-market.html#form

Report Highlights: `
Market Size in 2030: USD 10.4 billion
Growth (CAGR): 6.7% during 2024-2030
Forecast Period: 2024-2030
Trend Period: 2018-2022
Base Year: 2023
Number of Segments Covered: 4
Number of Tables & Graphs: 100+
Country-Level Market Assessment: 20

Segment Insights on the Non-Drug-Eluting Device Market:
The global Non-Drug-Eluting Device Market is segmented by application type, degradability type, end-user type and region

Based on application type: The global non-drug-eluting device market is segmented into implants and sutures. Implants are expected to remain the dominant and fastest-growing application type in the market during the forecast period.
Implants are used in various medical-surgical procedures in the current market and are expected to grow rapidly with increasing cardiovascular, orthopedic, and neurological implants.
Non-drug-eluting sutures are being increasingly used for surgical incisions in various types of surgeries. They are used to repair skin lacerations and traumatic wounds in the human body and hence are required where permanent sutures are not required.

Based on degradability type: The market is segmented into biodurable and bioresorbable. Biodurable is expected to remain the dominant and fastest-growing degradable type in the market during the forecast period. Biodurable implants are highly used in the market. These implants are designed to serve as mechanical support for a longer duration or indefinitely depending on the requirements. Bioresorbable sutures are mostly used in surgical devices requiring absorption by the body over a certain period.

Based on end-user type: The market is segmented into hospitals and ambulatory surgical centers. Hospitals remain a key end-user market with increasing implant procedures in the hospitals. Also, sutures continue to be highly used in hospitals. Ambulatory surgical centers' strong growth is due to rising demand for urgent sutures in the market.

To know the most attractive segments, click here for a free sample of the report:
https://www.stratviewresearch.com/Request-Sample/3849/non-drug-eluting-device-market.html#form

Which Region Shows the Most Promising Growth Forecast and Opportunity?
The analysis suggests that North America is expected to remain the largest and fastest growing for non-drug-eluting devices during the forecast period. This growth outlook is majorly attributed to the following-
• North America's dominance in the market is driven by high implant surgeries in the region and the increased demand for biocompatible sutures in the region.
• The region has also got leading manufacturers of non-drug-eluting devices like Medtronic plc. and Johnson & Johnson. The region will show exceptional growth in the coming years with new medical implants getting approved by the FDA in the market.

Asia-Pacific is also a strong growth region with new fuelled demand for implant procedures in the region mainly for orthopedic implants in countries like China and India.

Non-Drug-Eluting Device Market Drivers:
The growth of the Non-Drug-Eluting Device Market is driven by several factors.
• Multiple factors are currently driving the market for non-drug-eluting devices à the increasing demand for implants for orthopedic, cardiovascular, and dental procedures, technological advancements leading to customized implants, and the growing need for effective wound closure.
• The market faces limitations primarily due to the extensive testing required for regulatory approval and the differing standards across regions.

Top 10 Companies in the Non-Drug-Eluting Device Market:
Stratview Research has identified the following companies as the top market players:
• B. Braun Melsungen AG
• Boston Scientific Corporation
• ConMed Corporation
• DemeTECH Corporation
• Integra Lifesciences
• Johnson & Johnson Services Inc.
• Medtronic
• Peter Surgical
• Smith & Nephew plc.
• Stryker Corporation

What Unique Insights Does this Report Offer?
This report provides comprehensive insights into the Non-Drug-Eluting Device Market, answering critical questions like:
• How big is the sales opportunity?
• Which regions offer the best sales opportunities?
• Which are the most attractive market segments?
• Which are the top players and their market positioning?
• How complex is the business environment?
• What are the factors affecting the market?

For Customization or Any Other Queries, Get in Touch with Our Industry Experts at - sales@stratviewresearch.com

Related Reports:
• Drug-Eluting Device Market: https://www.stratviewresearch.com/3848/drug-eluting-device-market.html

400 Renaissance Center, Suite 2600,
Detroit, Michigan, MI 48243
United States of America

Website: www.stratviewresearch.com
Mail Us: sales@stratviewresearch.com
Press: media@stratviewresearch.com
Call Us: +13133074176

Stratview Research is a global market research firm that highly specializes in aerospace & defense, chemicals, and a few other industries.
It launches a limited number of reports annually on the above-mentioned specializations. Thorough analysis and accurate forecasts in this report enable the readers to take convincing business decisions.
Stratview Research has been helping companies meet their global and regional growth objectives by offering customized research services. These include market assessment, due diligence, opportunity screening, voice of customer analysis, market entry strategies, and more.

This release was published on openPR.